STOCK TITAN
  1. Home
  2. News
  3. GILD

Gilead Sciences, Inc. - GILD STOCK NEWS

IMPACT
SENTIMENT
GILD : Nasdaq
Real-World Evidence Reinforces Biktarvy® as a Long-Term Treatment Option With a High Barrier to Resistance for People With HIV and a Range of Comorbidities
IMPACT
SENTIMENT
GILD : Nasdaq
Gilead Sciences Announces New Clinical Trial in Europe to Assess Lenacapavir for HIV Prevention as Part of Landmark Purpose Program
clinical trial
IMPACT
SENTIMENT
GILD : NYSE
Gilead Sciences: Leading With Passion and Purpose: Sandra’s Story
IMPACT
SENTIMENT
GILD : Nasdaq ASMB : Nasdaq
Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases
partnership
IMPACT
SENTIMENT
GILD : Nasdaq
Gilead and Kite Oncology Present Important New Data Across Multiple Difficult-to-Treat Cancers at ESMO Congress 2023
IMPACT
SENTIMENT
GILD : Nasdaq
Gilead Demonstrates the Impact of Global Collaboration in Advancing HIV Research and Health Equity at EACS 2023
IMPACT
SENTIMENT
GILD : Nasdaq
Gilead Sciences to Release Third Quarter 2023 Financial Results on Tuesday, November 7, 2023
earnings
IMPACT
SENTIMENT
GILD : Nasdaq
Gilead to Present Latest Innovative Virology Data on Current and Potentially Transformative Therapies Across HIV and COVID-19 at IDWeek 2023
conferences covid-19
IMPACT
SENTIMENT
GILD : Nasdaq
Gilead Board Director Kevin E. Lofton Named to List of Influential Leaders
IMPACT
SENTIMENT
GILD : Nasdaq
CHMP Adopts Positive Opinion to Extend the Use of Veklury® (Remdesivir) to Treat COVID-19 in People With Hepatic Impairment
covid-19
Stock GILD logo
Gilead Sciences, Inc.
Nasdaq:GILD

GILD Stock Data

Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link

About GILD

Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.